| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 6.636 | 768 | 1.115 | 0 | 2.179 |
| Total Income - EUR | - | - | - | - | 0 | 6.636 | 23.320 | 5.495 | 0 | 2.179 |
| Total Expenses - EUR | - | - | - | - | 3.936 | 16.661 | 8.622 | 2.425 | 1.537 | 2.348 |
| Gross Profit/Loss - EUR | - | - | - | - | -3.936 | -10.025 | 14.698 | 3.070 | -1.537 | -168 |
| Net Profit/Loss - EUR | - | - | - | - | -3.936 | -10.090 | 14.678 | 3.036 | -1.537 | -168 |
| Employees | - | - | - | - | 2 | 2 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Gamoterm Ady-Ionut S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 6.818 | 6.303 | 5.237 | 4.138 | 3.038 |
| Current Assets | - | - | - | - | 71 | 6.171 | 362 | 1.354 | 870 | 1.773 |
| Inventories | - | - | - | - | 0 | 1.903 | 267 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 113 | 0 | 0 | 0 | 79 |
| Cash | - | - | - | - | 71 | 4.155 | 95 | 1.354 | 870 | 1.694 |
| Shareholders Funds | - | - | - | - | -3.894 | -13.910 | 1.077 | 4.116 | 2.567 | 2.384 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 3.122 | 3.836 | 5.588 | 2.474 | 2.441 | 2.427 |
| Income in Advance | - | - | - | - | 843 | 23.063 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2223 - 2223" | |||||||||
| CAEN Financial Year |
2223
|
|||||||||
Comments - Gamoterm Ady-Ionut S.r.l.